ArticleOncology reports2017

EPAC1 overexpression is a prognostic marker and its inhibition shows promising therapeutic potential for gastric cancer.

Ding-Ping Sun et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.